Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 8/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29838836 | 0.94 | LPL (0.43) | LPLLIPGMEN1MAPTKMT2A | |
| SCHEMBL793279 | 0.94 | LPL (0.43) | LPLLIPGMEN1MAPTKMT2A | |
| SCHEMBL13867264 | 0.88 | LPL (0.40) | LPLLIPG | |
| SCHEMBL2135982 | 0.88 | LPL (0.37) | LPLLIPGMEN1MAPTKMT2A | |
| SCHEMBL5095856 | 0.83 | LIPG (0.47) | LPLLIPGPRMT5WDR77ROCK1 | |
| SCHEMBL24739581 | 0.81 | LPL (0.35) | LPLLIPG | |
| SCHEMBL3721035 | 0.81 | L3MBTL1 (0.46) | MEN1MAPTKMT2AL3MBTL1CA2 | |
| SCHEMBL29377775 | 0.81 | L3MBTL1 (0.46) | MEN1MAPTKMT2AL3MBTL1CA2 | |
| SCHEMBL5095697 | 0.81 | LPL (0.48) | LPLLIPGMEN1KMT2AL3MBTL1 | |
| SCHEMBL679083 | 0.81 | MEN1 (0.31) | MEN1MAPTKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190296242-A1 | POLYMERS WITH ASYMMETRIC REPEATING UNITS | MERCK PATENT GMBH (DE) | 2019-09-26 | — | — | US | disclosed |
| WO-2018099847-A1 | POLYMERS WITH ASYMMETRIC REPEATING UNITS | MERCK PATENT GMBH (DE) | 2018-06-07 | — | — | WO | disclosed |
| US-9708529-B2 | Bulk polymer composites | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-07-18 | — | — | US | disclosed |
| US-9028728-B2 | Photochromic materials that include indeno-fused naphthopyrans | TRANSITIONS OPTICAL, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-20140346400-A1 | BULK POLYMER COMPOSITES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-11-27 | — | — | US | disclosed |
| WO-2013090610-A1 | BULK POLYMER COMPOSITES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-06-20 | — | — | WO | disclosed |
| US-20120145973-A1 | Photochromic Materials That Include Indeno-Fused Naphthopyrans | TRANSITIONS OPTICAL INC. (US) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120145973-A1 | Photochromic Materials That Include Indeno-Fused Naphthopyrans | NQO1, INTS6, IPO4 | LPL 3880/4885LIPG 2791/4885MEN1 4483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.